T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Antero Resources
AR
$11.4B
| $13.7M | ﹤0.01% |
397,943
+314,793
| +379% | +$12.5M |
|
1252
Bio-Rad Laboratories Class A
BIO
$9.62B
| $13.6M | ﹤0.01% |
90,490
+38,900
| +75% | +$5.57M |
|
1253
Shopify
SHOP
$200B
| $13.6M | ﹤0.01% |
+4,013,500
| New | +$12.5M |
|
1254
Accuray
ARAY
$32.6M
| $13.6M | ﹤0.01% |
2,020,907
+681,737
| +51% | +$5.08M |
|
1255
Opko Health
OPK
$993M
| $13.6M | ﹤0.01% |
845,700
+174,000
| +26% | +$2.71M |
|
|
BWLD
1256
DELISTED
Buffalo Wild Wings, Inc.
BWLD
| $13.5M | ﹤0.01% |
86,300
+1,800
| +2% | +$294K |
|
|
BIG
1257
DELISTED
Big Lots, Inc.
BIG
| $13.5M | ﹤0.01% |
300,300
+44,400
| +17% | +$2.07M |
|
|
AXON
1258
Axon Enterprise
AXON
$49.9B
| $13.5M | ﹤0.01% |
404,145
+373,985
| +1,240% | +$11.7M |
|
1259
Targa Resources
TRGP
$58.8B
| $13.4M | ﹤0.01% |
150,700
+12,100
| +9% | +$1.18M |
|
1260
Navient
NAVI
$848M
| $13.3M | ﹤0.01% |
733,033
+14,790
| +2% | +$289K |
|
|
BPMC
1261
DELISTED
Blueprint Medicines
BPMC
| $13.3M | ﹤0.01% |
+503,550
| New | +$14.4M |
|
1262
Essent Group
ESNT
$6.23B
| $13.3M | ﹤0.01% |
484,470
-1,800
| -0.4% | -$46.3K |
|
|
CAS
1263
DELISTED
A M Castle & Co
CAS
| $13.2M | ﹤0.01% |
2,142,599
-66,200
| -3% | -$341K |
|
1264
Xencor
XNCR
$1.69B
| $13.2M | ﹤0.01% |
601,129
+128,700
| +27% | +$2.19M |
|
1265
Hormel Foods
HRL
$13.5B
| $13.1M | ﹤0.01% |
466,096
+16,600
| +4% | +$470K |
|
|
FDO
1266
DELISTED
FAMILY DOLLAR STORES
FDO
| $13.1M | ﹤0.01% |
166,683
+1,600
| +1% | +$126K |
|
|
TGNA
1267
DELISTED
TEGNA Inc
TGNA
| $13M | ﹤0.01% |
635,439
-131,438
| -17% | -$2.47M |
|
|
CATM
1268
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $13M | ﹤0.01% |
351,594
+12,100
| +4% | +$459K |
|
1269
Sixth Street Specialty
TSLX
$1.79B
| $12.9M | ﹤0.01% |
761,640
+2,600
| +0.3% | +$46.8K |
|
|
PLG
1270
Platinum Group Metals
PLG
$189M
| $12.9M | ﹤0.01% |
328,715
+2,485
| +0.8% | +$115K |
|
1271
Cincinnati Financial
CINF
$26.6B
| $12.9M | ﹤0.01% |
256,209
+790
| +0.3% | +$40.7K |
|
|
XRM
1272
DELISTED
Xerium Technologies Inc (new)
XRM
| $12.8M | ﹤0.01% |
700,554
+205,554
| +42% | +$3.62M |
|
1273
Jacobs Solutions
J
$16.9B
| $12.7M | ﹤0.01% |
377,567
-623,963
| -62% | -$22.8M |
|
1274
Fossil Group
FOSL
$319M
| $12.6M | ﹤0.01% |
181,171
-3,905
| -2% | -$303K |
|
|
POM
1275
DELISTED
PEPCO HOLDINGS, INC.
POM
| $12.5M | ﹤0.01% |
465,800
+4,600
| +1% | +$122K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.